These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21778595)

  • 1. Incidence of late thromboembolic events after catheter ablation of atrial fibrillation.
    Yagishita A; Takahashi Y; Takahashi A; Fujii A; Kusa S; Fujino T; Nozato T; Kuwahara T; Hirao K; Isobe M
    Circ J; 2011; 75(10):2343-9. PubMed ID: 21778595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
    Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.
    Mardigyan V; Verma A; Birnie D; Guerra P; Redfearn D; Becker G; Champagne J; Sapp J; Gula L; Parkash R; Macle L; Crystal E; O'Hara G; Khaykin Y; Sturmer M; Veenhuyzen GD; Greiss I; Sarrazin JF; Mangat I; Novak P; Skanes A; Roux JF; Chauhan V; Hadjis T; Morillo CA; Essebag V
    Can J Cardiol; 2013 Feb; 29(2):219-23. PubMed ID: 22840300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.
    Uhm JS; Won H; Joung B; Nam GB; Choi KJ; Lee MH; Kim YH; Pak HN
    Yonsei Med J; 2014 Sep; 55(5):1238-45. PubMed ID: 25048480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
    Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors.
    Zuern CS; Kilias A; Berlitz P; Seizer P; Gramlich M; Müller K; Duckheim M; Gawaz M; Schreieck J
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):688-93. PubMed ID: 25753968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
    Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W
    Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic risk and anticoagulation strategies in patients undergoing catheter ablation for atrial fibrillation.
    Viles-Gonzalez JF; Mehta D
    Curr Cardiol Rep; 2011 Feb; 13(1):38-42. PubMed ID: 21057900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can catheter ablation reduce the incidence of thromboembolic events in patients with atrial fibrillation?: Protocol for a systematic review and meta-analysis.
    Liu M; Wang Y; Chen X; Li X; Zhuang X; Wang L
    Medicine (Baltimore); 2017 Dec; 96(48):e8479. PubMed ID: 29310330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study.
    Di Biase L; Gaita F; Toso E; Santangeli P; Mohanty P; Rutledge N; Yan X; Mohanty S; Trivedi C; Bai R; Price J; Horton R; Gallinghouse GJ; Beheiry S; Zagrodzky J; Canby R; Leclercq JF; Halimi F; Scaglione M; Cesarani F; Faletti R; Sanchez J; Burkhardt JD; Natale A
    Heart Rhythm; 2014 May; 11(5):791-8. PubMed ID: 24607716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
    Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
    Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation.
    Liang JJ; Elafros MA; Mullen MT; Muser D; Hayashi T; Enriquez A; Pathak RK; Zado ES; Santangeli P; Arkles JS; Schaller RD; Supple GE; Frankel DS; Garcia FC; Deo R; Lin D; Riley MP; Nazarian S; Dixit S; Marchlinski FE; Callans DJ
    J Cardiovasc Electrophysiol; 2018 Jun; 29(6):823-832. PubMed ID: 29513397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Investigation on Anticoagulation Management Before and After Catheter Ablation for Atrial Fibrillation in Japan　- Periprocedural and Long-Term Outcomes.
    Nogami A; Soejima K; Morishima I; Hiroshima K; Kato R; Sakagami S; Miura F; Okawa K; Kimura T; Inoue T; Takita A; Uno K; Kumagai K; Kurita T; Gosho M; Aonuma K;
    Circ J; 2022 Dec; 87(1):50-62. PubMed ID: 35989303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peri-interventional combined anticoagulation and antithrombotic therapy in atrial fibrillation ablation: A retrospective safety analysis.
    Klee K; Widulle D; Duckheim M; Gramlich M; Frische C; Gawaz M; Seizer P; Eick C; Schreieck J
    Cardiol J; 2018; 25(2):213-220. PubMed ID: 28980285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolism after atrioventricular node ablation and pacing: long term follow up.
    Gasparini M; Mantica M; Brignole M; Gianfranchi L; Menozzi C; Pizzetti F; Magenta G; Delise P; Proclemer A; Tognarin S; Ometto R; Acquati F; Mantovan R; Turco P; De Ferrari GM
    Heart; 1999 Oct; 82(4):494-8. PubMed ID: 10490567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation.
    Nedios S; Kornej J; Koutalas E; Bertagnolli L; Kosiuk J; Rolf S; Arya A; Sommer P; Husser D; Hindricks G; Bollmann A
    Heart Rhythm; 2014 Dec; 11(12):2239-46. PubMed ID: 25128733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.
    Blandino A; Bianchi F; Biondi-Zoccai G; Grossi S; Conte MR; Rametta F; Gaita F
    J Interv Card Electrophysiol; 2016 Sep; 46(3):225-36. PubMed ID: 27217030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.